Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects
Clinical trial NCT04686994 · COMPLETED
Trial details
- NCT number
- NCT04686994
- Sponsor
- Gannex Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2021-01-19
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.